Literature DB >> 20511407

Ethnic differences in resistance artery contractility of normotensive pregnant women.

L M Brewster1, Z Taherzadeh, S Volger, J F Clark, T Rolf, H Wolf, E Vanbavel, G A van Montfrans.   

Abstract

Black women are at a greater risk to develop hypertension during pregnancy, with a 4.5 times higher rate of fatal preeclampsia than white women. Therefore, it is important to identify factors that may affect this risk. Our group previously proposed that high activity of the central regulatory enzyme of energy metabolism, creatine kinase (CK), may increase ATP-buffering capacity and lead to enhanced vascular contractility and reduced nitric oxide bioavailability. Therefore, we assessed microvascular contractility characteristics in isolated resistance arteries from self-defined black and white normotensive pregnant women using a Mulvany-Halpern myograph. Additionally, morphology was assessed with electron microscopy. Resistance-sized arteries obtained from omentum donated during cesarean sections (11 black women and 20 white women, mean age: 34 yr) studied in series showed similar morphology but significantly greater maximum contractions to norepinephrine (10(-5) M) in blacks [14.0 mN (1.8 SE)] compared with whites [8.9 mN (1.4 SE), P = 0.02]. Furthermore, we found greater residual contractility after the specific CK inhibitor dinitrofluorobenzene (10(-6) M) in black women [55% (6 SE)] compared with white women [28% (4 SE), P = 0.001] and attenuated vasodilation after bradykinin (10(-7) M) in black women [103% (6 SE)] compared with white women [84% (5 SE), P = 0.023], whereas responses to sodium nitroprusside (10(-4) M) and amlodipine (10(-6) M) were similar. We conclude that compared with white women, normotensive pregnant black women display greater resistance artery contractility and evidence of higher vascular CK activity with attenuated nitric oxide synthesis. These findings in normotensives may imply that the black population is at risk for a further incline in pregnancy-related hypertensive disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20511407     DOI: 10.1152/ajpheart.00919.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  9 in total

Review 1.  Creatine kinase, energy reserve, and hypertension: from bench to bedside.

Authors:  Lizzy M Brewster
Journal:  Ann Transl Med       Date:  2018-08

2.  Population differences in associations of serotonin transporter promoter polymorphism (5HTTLPR) di- and triallelic genotypes with blood pressure and hypertension prevalence.

Authors:  Redford B Williams; George D Bishop; Brett C Haberstick; Andrew Smolen; Beverly H Brummett; Ilene C Siegler; Michael A Babyak; Xiaodong Zhang; E Shyong Tai; Jeannette Jen-Mai Lee; Maudrene Tan; Yik Ying Teo; Shiwei Cai; Edmund Chan; Carolyn Tucker Halpern; Eric A Whitsel; Shawn Bauldry; Kathleen Mullan Harris
Journal:  Am Heart J       Date:  2016-12-29       Impact factor: 4.749

3.  Blood pressure changes during pregnancy: impact of race, body mass index, and weight gain.

Authors:  Urania Magriples; Marcella H Boynton; Trace S Kershaw; Kathleen O Duffany; Sharon Schindler Rising; Jeannette R Ickovics
Journal:  Am J Perinatol       Date:  2012-10-11       Impact factor: 1.862

Review 4.  Racial disparities in cardiovascular disease risk: mechanisms of vascular dysfunction.

Authors:  R Matthew Brothers; Paul J Fadel; David M Keller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-08-09       Impact factor: 4.733

5.  Creatine kinase, sodium retention, and blood pressure: Is there a link?

Authors:  Roberto Pisoni; Mehrdad Hamrahian; Tibor Fülöp
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-22       Impact factor: 3.738

6.  The risk of hypertension and cardiovascular disease in women with uterine fibroids.

Authors:  Yentl C Haan; Frederieke S Diemer; Lisa Van Der Woude; Gert A Van Montfrans; Glenn P Oehlers; Lizzy M Brewster
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-22       Impact factor: 3.738

7.  Creatine kinase as predictor of blood pressure and hypertension. Is it all about body mass index? A follow-up study of 250 patients.

Authors:  Stein H Johnsen; Hallvard Lilleng; Svein I Bekkelund
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-10-03       Impact factor: 3.738

8.  The acute effect of beta-guanidinopropionic acid versus creatine or placebo in healthy men (ABC Trial): study protocol for a randomized controlled trial.

Authors:  Fares A Karamat; Deborah L Horjus; Yentl C Haan; Lisa van der Woude; Inge Oudman; Gert A van Montfrans; Joseph F Clark; Lizzy M Brewster
Journal:  Trials       Date:  2015-02-22       Impact factor: 2.279

Review 9.  Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review.

Authors:  Lizzy M Brewster; Yackoob K Seedat
Journal:  BMC Med       Date:  2013-05-30       Impact factor: 8.775

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.